LUCY Q1 2026 Earnings EPS Surprises with a 2282 Beat Despite Missing Revenue Details Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline REG Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Reaction Adagene Inc ADAG Q2 2025 Earnings EPS Misses Estimates Amid RD Progress Burlington Stores BURL Q1 2026 Earnings EPS Beat Lifts Stock as OffPrice Model Proves Resilient Eikon Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline